S100A5 and sarcoma: However, there was no significant negative correlation between S100A5 and TIICs in other carcinomas, such as lung adenocarcinoma (LUAD), sarcoma (SARC), breast invasive carcinoma (BRCA), and colon adenocarcinoma (COAD) (Figure S3F, Supporting Information).